Details of Drug

Drug General Information (ID: D1581)
Drug Name	Ticlopidine
Drug Type	Small molecule
Drug Synonymous	Ticlid; Ticlopidina; Ticlopidinum; PCR 5332; Ticlid (TN); Ticlopidin-Puren; Ticlopidina [INN-Spanish]; Ticlopidine (INN); Ticlopidine [INN:BAN]; Ticlopidinum [INN-Latin]; Ticlopidin-Puren (TN); 5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine; 5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine Click to Show/Hide
Disease Class	8B20: Ischaemic/haemorrhagic stroke
Therapeutic Class	Fibrinolytic Agents
Structure
Structure	3D Structure		2D Structure
Formula	C14H14ClNS
InChI	1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2
InChIKey	PHWBOXQYWZNQIN-UHFFFAOYSA-N
Canonical SMILES	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
External Link
	Pubchem ID	5472
	CAS Number	55142-85-3
	CHEBI ID	9588
	TTD ID	D05LBU
	INTEDE ID	DR1592
	VARIDT ID	DR00842

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM005 Altered gastric pH BM017 CYP450 enzyme inhibition BM050 Increased risk of bleeding BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Ticlopidine
Affected gastrointestinal absorption
	Altered gastric pH					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0049		Aluminum hydroxide	AlH3O3	10176082	Minor		Inter Info	[91]
D0236		Calcium carbonate	CCaO3	10112	Minor		Inter Info	[91]
D0967		Magaldrate	AlHMgO5S+2	3086011	Minor		Inter Info	[91]
D0968		Magnesium carbonate	CMgO3	11029	Minor		Inter Info	[91]
D0973		Magnesium hydroxide	H2MgO2	14791	Minor		Inter Info	[91]
D0974		Magnesium oxide	MgO	14792	Minor		Inter Info	[91]
D1480		Sodium bicarbonate	CHNaO3	516892	Minor		Inter Info	[91]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 43
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0336		Cilostazol	C20H27N5O2	2754	Major		Inter Info	[11], [23], [24], [25]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[26], [27], [28]
D0364		Clopidogrel	C16H16ClNO2S	60606	Major		Inter Info	[29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44]
D1385		Rasagiline	C12H13N	3052776	Major		Inter Info	[21], [11], [65]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[69], [70], [71]
D1596		Tizanidine	C9H8ClN5S	5487	Major		Inter Info	[73], [74], [75], [76], [77], [78], [79], [80]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[95]
D0043		Alosetron	C17H18N4O	2099	Moderate		Inter Info	[146]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Moderate		Inter Info	[147]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[150]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[151]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[152], [153], [154]
D0157		Bendamustine	C16H21Cl2N3O2	65628	Moderate		Inter Info	[155]
D0220		Bupropion	C13H18ClNO	444	Moderate		Inter Info	[21], [57], [11], [159], [160], [161], [162], [163], [164], [165], [166], [167]
D0356		Clobazam	C16H13ClN2O2	2789	Moderate		Inter Info	[169]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182]
D0424		Darifenacin	C28H30N2O2	444031	Moderate		Inter Info	[183], [153]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[21], [11], [185], [61], [153], [186]
D0562		Eluxadoline	C32H35N5O5	11250029	Moderate		Inter Info	[187]
D0621		Ethotoin	C11H12N2O2	3292	Moderate		Inter Info	[202], [203], [204]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[205]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[11], [206]
D0655		Fesoterodine	C26H37NO3	6918558	Moderate		Inter Info	[207]
D0665		Flibanserin	C20H21F3N4O	6918248	Moderate		Inter Info	[208]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[209], [210], [211], [202], [203], [212], [213], [91], [214], [204]
D0916		Levobupivacaine	C18H28N2O	92253	Moderate		Inter Info	[11], [247]
D1143		Nitisinone	C14H10F3NO5	115355	Moderate		Inter Info	[191], [21], [11]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[209], [210], [211], [202], [203], [212], [213], [91], [214], [204]
D1292		Pimozide	C28H29F2N3O	16362	Moderate		Inter Info	[252], [253]
D1299		Pirfenidone	C12H11NO	40632	Moderate		Inter Info	[11], [254]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[11], [176], [255]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[256]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[11], [257], [258]
D1427		Ropinirole	C16H24N2O	5095	Moderate		Inter Info	[259], [260]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[11], [66], [264]
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[265]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Moderate		Inter Info	[267], [268], [269]
D0208		Brivaracetam	C11H20N2O2	9837243	Minor		Inter Info	[11], [287]
D0248		Cannabidiol	C21H30O2	644019	Minor		Inter Info	[11], [288]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[293], [176], [294], [295]
D1265		Phenobarbital	C12H12N2O3	4763	Minor		Inter Info	[296]
D1383		Ranolazine	C24H33N3O4	56959	Minor		Inter Info	[297]
D1607		Tolterodine	C22H31NO	443879	Minor		Inter Info	[298], [299], [176]
Pharmacodynamic additive effects
	Increased risk of bleeding					Drug Num: 123
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0005		Abciximab	NA	NA	Major		Inter Info	[1], [2], [3], [4]
D0537		Drotrecogin alfa	NA	NA	Major		Inter Info	[5]
D0588		Eptifibatide	C35H49N11O9S2	448812	Major		Inter Info	[1], [2], [3], [4]
D0784		Ibritumomab tiuxetan	NA	NA	Major		Inter Info	[6]
D0904		Lepirudin	C287H440N80O111S6	118856773	Major		Inter Info	[7], [8], [9]
D0008		Acalabrutinib	C26H23N7O2	71226662	Major		Inter Info	[10]
D0096		Apixaban	C25H25N5O4	10182969	Major		Inter Info	[11], [12]
D0102		Ardeparin	C26H42N2O37S5	772	Major		Inter Info	[13], [14], [15]
D0104		Argatroban	C23H36N6O5S	92722	Major		Inter Info	[7], [8], [9]
D0129		Avapritinib	C26H27FN10	118023034	Major		Inter Info	[11], [16]
D0176		Betrixaban	C23H22ClN5O3	10275777	Major		Inter Info	[17], [18]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[19]
D0247		Cangrelor	C17H25Cl2F3N5O12P3S2	9854012	Major		Inter Info	[17], [11], [20]
D0250		Caplacizumab	NA	NA	Major		Inter Info	[21], [11], [22]
D0414		Dalteparin	C26H42N2O37S5	772	Major		Inter Info	[45], [46], [13], [47], [14], [15], [48]
D0415		Danaparoid	NA	NA	Major		Inter Info	[13], [14], [15]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[49]
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[50], [51]
D0435		Defibrotide	C20H21N4O6P	135565962	Major		Inter Info	[11], [52]
D0447		Desirudin	C287H440N80O110S6	16129703	Major		Inter Info	[53], [54]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Major		Inter Info	[55]
D0574		Enoxaparin	C26H42N2O37S5	772	Major		Inter Info	[45], [46], [13], [47], [14], [15], [48]
D0690		Fondaparinux	C31H53N3O49S8	5282448	Major		Inter Info	[45], [46], [13], [47], [14], [15], [48]
D0785		Ibrutinib	C25H24N6O2	24821094	Major		Inter Info	[56], [57], [11], [58]
D0805		Inotersen	C230H318N69O121P19S19	121492004	Major		Inter Info	[11], [50], [59]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Major		Inter Info	[50], [60]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[21], [11], [61]
D1313		Ponatinib	C29H27F3N6O	24826799	Major		Inter Info	[62]
D1328		Prasugrel	C20H20FNO3S	6918456	Major		Inter Info	[11], [63]
D1380		Ramucirumab	NA	NA	Major		Inter Info	[64]
D1387		Regorafenib	C21H15ClF4N4O3	11167602	Major		Inter Info	[11], [66], [67]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Major		Inter Info	[68]
D1588		Tinzaparin	C26H42N2O37S5	772	Major		Inter Info	[13], [14], [15]
D1592		Tipranavir	C31H33F3N2O5S	54682461	Major		Inter Info	[72]
D1593		Tirofiban	C22H36N2O5S	60947	Major		Inter Info	[1], [2], [3], [4]
D1623		Trastuzumab emtansine	NA	NA	Major		Inter Info	[21], [11], [81]
D1705		Vorapaxar	C29H33FN2O4	10077130	Major		Inter Info	[82]
D1718		Zanubrutinib	C27H29N5O3	135565884	Major		Inter Info	[50]
D1613		Tositumomab	NA	NA	Major		Inter Info	[83], [84]
D1614		Tositumomab (I-131)	NA	NA	Major		Inter Info	[83], [84]
D0047		Alteplase	NA	NA	Moderate		Inter Info	[85], [86], [87], [88], [89], [90], [91], [92]
D0088		Anistreplase	NA	NA	Moderate		Inter Info	[85], [87], [92]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[93], [11], [94]
D0189		Bivalirudin	C98H138N24O33	16129704	Moderate		Inter Info	[8]
D0384		Collagenase clostridium histolyticum	NA	NA	Moderate		Inter Info	[96]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1815		Icosapent	C20H30O2	446284	Moderate		Inter Info	[11], [134], [135]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[93], [21], [11], [94], [136], [137], [138], [139], [140], [141], [142], [143], [144]
D1395		Reteplase	NA	NA	Moderate		Inter Info	[85], [86], [87], [88], [89], [90], [91], [92]
D1506		Streptokinase	C11H19NO2	9815560	Moderate		Inter Info	[85], [87], [92]
D1550		Tenecteplase	NA	NA	Moderate		Inter Info	[85], [86], [87], [88], [89], [90], [91], [92]
D0017		Acetylsalicylic acid	C9H8O4	2244	Moderate		Inter Info	[91], [145]
D0087		Anisindione	C16H12O3	2197	Moderate		Inter Info	[148], [149], [91]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[93], [21], [11], [94], [136], [137], [138], [139], [140], [141], [142], [143], [144]
D0210		Bromfenac	C15H12BrNO3	60726	Moderate		Inter Info	[91]
D0211		Bromfenac (ophthalmic)	C15H12BrNO3	60726	Moderate		Inter Info	[156], [157], [158]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[93], [21], [11], [94], [136], [137], [138], [139], [140], [141], [142], [143], [144]
D0298		Celecoxib	C17H14F3N3O2S	2662	Moderate		Inter Info	[168]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1769		Deoxycholic acid	C24H40O4	222528	Moderate		Inter Info	[50], [184]
D0451		Desvenlafaxine	C16H25NO2	125017	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D0457		Dexfenfluramine	C12H16F3N	66265	Moderate		Inter Info	[100], [128], [129]
D0476		Diclofenac	C14H11Cl2NO2	3033	Moderate		Inter Info	[91]
D0477		Diclofenac (ophthalmic)	C14H11Cl2NO2	3033	Moderate		Inter Info	[156], [157], [158]
D0478		Diclofenac (topical)	C14H11Cl2NO2	3033	Moderate		Inter Info	[156], [157], [158]
D0481		Dicoumarol	C19H12O6	54676038	Moderate		Inter Info	[148], [149], [91]
D0489		Diflunisal	C13H8F2O3	3059	Moderate		Inter Info	[91]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D0586		Epoprostenol	C20H32O5	5282411	Moderate		Inter Info	[188], [189], [190]
D0599		Escitalopram	C20H21FN2O	146570	Moderate		Inter Info	[98], [191], [21], [11], [192], [193], [103], [104], [105], [194], [195], [196], [197], [198], [199], [200], [120], [128], [129], [201], [132]
D0624		Etodolac	C17H21NO3	3308	Moderate		Inter Info	[91]
D0641		Fenfluramine	C12H16F3N	3337	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D0645		Fenoprofen	C15H14O3	3342	Moderate		Inter Info	[91]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D0680		Flurbiprofen	C15H13FO2	3394	Moderate		Inter Info	[91]
D0681		Flurbiprofen (ophthalmic)	C15H13FO2	3394	Moderate		Inter Info	[156], [157], [158]
D0711		Garlic	NA	NA	Moderate		Inter Info	[215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229]
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[230], [231], [232], [233], [217], [234], [235], [218], [220], [221], [236], [237], [238], [224], [239], [240], [241], [227], [242]
D0723		Ginseng	C42H66O17	420552	Moderate		Inter Info	[243], [244], [245]
D0752		Hemin	C34H32FeN4O4	26945	Moderate		Inter Info	[246]
D0753		Heparin	C26H42N2O37S5	772	Moderate		Inter Info	[91]
D0786		Ibuprofen	C13H18O2	3672	Moderate		Inter Info	[91]
D0792		Iloprost	C22H32O4	5311181	Moderate		Inter Info	[188], [189], [190]
D0800		Indomethacin	C19H16ClNO4	3715	Moderate		Inter Info	[91]
D0881		Ketoprofen	C16H14O3	3825	Moderate		Inter Info	[91]
D0882		Ketorolac	C15H13NO3	3826	Moderate		Inter Info	[91]
D0883		Ketorolac (ophthalmic)	C15H13NO3	3826	Moderate		Inter Info	[156], [157], [158]
D0920		Levomilnacipran	C15H22N2O	6917779	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D0988		Meclofenamic acid	C14H11Cl2NO2	4037	Moderate		Inter Info	[91]
D0991		Mefenamic acid	C15H15NO2	4044	Moderate		Inter Info	[91]
D0995		Meloxicam	C14H13N3O4S2	54677470	Moderate		Inter Info	[91]
D1066		Milnacipran	C15H22N2O	65833	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1097		Nabumetone	C15H16O2	4409	Moderate		Inter Info	[91]
D1109		Naproxen	C14H14O3	156391	Moderate		Inter Info	[91]
D1123		Nepafenac (ophthalmic)	C15H14N2O2	151075	Moderate		Inter Info	[156], [157], [158]
D1139		Nintedanib	C31H33N5O4	135423438	Moderate		Inter Info	[248]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[11], [249]
D1178		Omega-3 fatty acids	C60H92O6	56842239	Moderate		Inter Info	[11], [134], [135]
D1196		Oxaprozin	C18H15NO3	4614	Moderate		Inter Info	[91]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1249		Pentosan polysulfate	C10H18O21S4	37720	Moderate		Inter Info	[50], [250]
D1251		Pentoxifylline	C13H18N4O3	4740	Moderate		Inter Info	[191], [251]
D1274		Phenylbutazone	C19H20N2O2	4781	Moderate		Inter Info	[91]
D1421		Rofecoxib	C17H14O4S	5090	Moderate		Inter Info	[168]
D1460		Selumetinib	C17H15BrClFN4O3	10127622	Moderate		Inter Info	[261], [262], [263]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1464		Sibutramine	C17H26ClN	5210	Moderate		Inter Info	[100], [128], [129]
D1520		Sulindac	C20H17FO3S	1548887	Moderate		Inter Info	[91]
D1523		Suprofen (ophthalmic)	C14H12O3S	5359	Moderate		Inter Info	[156], [157], [158]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[11], [266]
D1606		Tolmetin	C15H15NO3	5509	Moderate		Inter Info	[91]
D1625		Treprostinil	C23H34O5	6918140	Moderate		Inter Info	[188], [189], [190]
D1674		Valdecoxib	C16H14N2O3S	119607	Moderate		Inter Info	[168]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[97], [98], [99], [100], [21], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [28], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133]
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[148], [86], [149], [91]
D1669		Urokinase	NA	NA	Moderate		Inter Info	[85], [86], [87], [88], [89], [90], [91], [92]
D1703		Vitamin E	C29H50O2	14985	Moderate		Inter Info	[261], [272], [11], [273], [274], [275], [276], [220], [277], [278], [279], [280], [281], [282], [283], [262], [284], [285], [263], [286]
D0253		Capsicum	NA	NA	Minor		Inter Info	[244]
D0309		Chamomile	C15H10O5	5280443	Minor		Inter Info	[244], [289], [224]
D0368		Clove	NA	NA	Minor		Inter Info	[220], [290], [291], [292]
D1661		Turmeric	C21H20O6	969516	Minor		Inter Info	[300], [220], [301]
Pharmacodynamic antagonistic effects
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1691		Verteporfin	C82H84N8O16	11980904	Moderate		Inter Info	[270], [271]

References
1	Klinkhardt U, Kirchmaier CM, Westrup D, Graff J, Mahnel R, Breddin HK, Harder S "Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A." Clin Pharmacol Ther 67 (2000): 305-13. [PMID: 10741635]
2	Product Information. Integrilin (eptifibatide). Schering Laboratories, Kenilworth, NJ.
3	Product Information. ReoPro (abciximab). Lilly, Eli and Company, Indianapolis, IN.
4	O'Donoghue M, Antman EM, Braunwald E, et al. "The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Pla" J Am Coll Cardiol 54 (2009): 678-85. [PMID: 19679245]
5	Product Information. Xigris (drotrecogin alfa). Lilly, Eli and Company, Indianapolis, IN.
6	Product Information. In-111 Zevalin (ibritumomab). IDEC Pharmaceuticals Corporation, San Diego, CA.
7	Product Information. Acova (argatroban) SmithKline Beecham, Philadelphia, PA.
8	Product Information. Angiomax (bivalirudin) The Medicines Compny, Cambridge, MA.
9	Product Information. Refludan (lepirudin). Hoechst Marion-Roussel Inc, Kansas City, MO.
10	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
11	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
12	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
13	Product Information. Fragmin (dalteparin). Pharmacia and Upjohn, Kalamazoo, MI.
14	Product Information. Lovenox (enoxaparin). Rhone-Poulenc Rorer, Collegeville, PA.
15	Product Information. Normiflo (ardeparin). Wyeth-Ayerst Laboratories, Philadelphia, PA.
16	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
17	Bodiford AB, Kessler FO, Fermo JD, Ragucci KR "Elevated international normalized ratio with the consumption of grapefruit and use of warfarin." SAGE Open Med Case Rep 0 (2013): 1-3. [PMID: 27489634]
18	Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
19	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
20	Product Information. Kengreal (cangrelor). The Medicines Company, Parsippany, NJ.
21	Cerner Multum, Inc. "Australian Product Information.".
22	Product Information. Cablivi (caplacizumab). Genzyme Corporation, Cambridge, MA.
23	Product Information. Pletal (cilostazol). Otsuka American Pharmaceuticals, Rockville, MD.
24	Suri A, Bramer SL "Effect of omeprazole on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 53-9. [PMID: 10702887]
25	Suri A, Forbes WP, Bramer SL "Effects of CYP3A inhibition on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 61-8. [PMID: 10702888]
26	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
27	Priskorn M, Larsen F, Segonzac A, Moulin M "Pharmacokinetic interaction study of citalopram and cimetidine in healhy subjects." Eur J Clin Pharmacol 52 (1997): 241-2. [PMID: 9218934]
28	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
29	Collet JP, Hulot JS, Pena A, et al. "Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study." Lancet 373 (2009): 309-17. [PMID: 19108880]
30	Frere C, Cuisset T, Morange PE, et al. "Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome." Am J Cardiol 101 (2008): 1088-1093. [PMID: 18394438]
31	Gilard M, Arnaud B, Cornily JC, et al "Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study." J Am Coll Cardiol 51 (2008): 256-60. [PMID: 18206732]
32	Gilard M, Arnaud B, Le Gal G, Abgrall JF, Boschat J "Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin." J Thromb Haemost 4 (2006): 2508-9. [PMID: 16898956]
33	Hirsh-Rokach B, Spectre G, Shai E, et al. "Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial." Pharmacotherapy 35 (2015): 140-147. [PMID: 25689244]
34	Hulot JS, Bura A, Villard E, et al. "Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects." Blood (2006):. [PMID: 16772608]
35	Juurlink DN, Gomes T, Ko DT, et al "A population-based study of the drug interaction between proton pump inhibitors and clopidogrel." CMAJ 180 (2009): 713-8. [PMID: 19176635]
36	Lau WC, Gurbel PA "The drug-drug interaction between proton pump inhibitors and clopidogrel." CMAJ 180 (2009): 699-700. [PMID: 19332744]
37	Li XQ, Andersson TB, Ahlstrom M, Weidolf L "Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities." Drug Metab Dispos 32 (2004): 821-7. [PMID: 15258107]
38	Mega JL, Close SL, Wiviott SD, et al. "Cytochrome p-450 polymorphisms and response to clopidogrel." N Engl J Med 360 (2009): 354-62. [PMID: 19106084]
39	Moayyedi P, Sadowski DC "Proton pump inhibitors and clopidogrel -- hazardous drug interaction or hazardous interpretation of data?" Can J Gastroenterol 23 (2009): 251-2. [PMID: 19373416]
40	Pezalla E, Day D, Pulliadath I "Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors." J Am Coll Cardiol 52 (2008): 1038-9. [PMID: 18786491]
41	Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B "Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel." Am Heart J 157 (2009): 148.e1-5. [PMID: 19081411]
42	Simon T, Verstuyft C, Mary-Krause M, et al "Genetic determinants of response to clopidogrel and cardiovascular events." N Engl J Med 360 (2009): 363-75. [PMID: 19106083]
43	Small DS, Farid NA, Payne CD, et al. "Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel." J Clin Pharmacol 48 (2008): 475-84. [PMID: 18303127]
44	Varenhorst C, Janes S, Erlinge D, et al "Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease." Eur Heart J 30 (2009): 1744-52. [PMID: 19429918]
45	Price AJ, Frcpath DO "Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?" Ann R Coll Surg Engl 77 (1995): 395. [PMID: 7486773]
46	Product Information. Arixtra (fondaparinux). Organon, West Orange, NJ.
47	Product Information. Innohep (tinzaparin) DuPont Pharmaceuticals, Wilmington, DE.
48	Product Information. Orgaran (danaparoid). Organon, West Orange, NJ.
49	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
50	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
51	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
52	Product Information. Defitelio (defibrotide). Jazz Pharmaceuticals, Palo Alto, CA.
53	Product Information. Ipravask (desirudin). Aventis Pharmaceuticals, Swiftwater, PA.
54	Product Information. Pradaxa (dabigatran). Boehringer-Ingelheim, Ridgefield, CT.
55	Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
56	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
57	Cerner Multum, Inc. "Canadian Product Information.".
58	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
59	Product Information. Tegsedi (inotersen). Akcea Therapeutics, Cambridge, MA.
60	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
61	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
62	Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
63	Product Information. Effient (prasugrel). Lilly, Eli and Company, Indianapolis, IN.
64	Product Information. Cyramza (ramucirumab). Eli Lilly and Company, Indianapolis, IN.
65	Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
66	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
67	Product Information. Stivarga (regorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
68	Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
69	Carrillo JA, Ramos SI, Herraiz AG, Llerena A, Agundez JAG, Berecz R, Duran M, Benitez J "Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients." J Clin Psychopharmacol 19 (1999): 494-9. [PMID: 10587283]
70	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
71	Greendyke RM, Gulya A "Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital." J Clin Psychiatry 49 (1988): 105-7. [PMID: 3346197]
72	Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
73	Granfors MT, Backman JT, Laitila J, Neuvonen PJ "Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro." Br J Clin Pharmacol 57 (2004): 349-53. [PMID: 14998432]
74	Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ "Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction." Clin Pharmacol Ther 75 (2004): 331-41. [PMID: 15060511]
75	Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ "Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism." Clin Pharmacol Ther 76 (2004): 598-606. [PMID: 15592331]
76	Momo K, Doki K, Hosono H, Homma M, Kohda Y "Drug interaction of tizanidine and fluvoxamine." Clin Pharmacol Ther 76 (2004): 509-10. [PMID: 15536467]
77	Momo K, Homma M, Kohda Y, Ohkoshi N, Yoshizawa T, Tamaoka A "Drug interaction of tizanidine and ciprofloxacin: Case report." Clin Pharmacol Ther 80 (2006): 717-9. [PMID: 17178273]
78	Product Information. Vioxx (rofecoxib). Merck & Co, Inc, West Point, PA.
79	Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
80	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
81	Product Information. Kadcyla (ado-trastuzumab). Genentech, South San Francisco, CA.
82	Product Information. Zontivity (vorapaxar). Merck & Company Inc, Whitehouse Station, NJ.
83	Product Information. Bexxar I 131 Therapeutic (iodine I 131 tositumomab). GlaxoSmithKline, Research Triangle Park, NC.
84	Product Information. BexxarTherapy (tositumomab). GlaxoSmithKline Inc, Oakville, IA.
85	Harder S, Klinkhardt U "Thrombolytics: drug interactions of clinical significance." Drug Saf 23 (2000): 391-9. [PMID: 11085346]
86	Hirsch J, Dalen J, Guyatt G, American College of Chest Physicians "The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Physicians." Chest 119(1 Suppl) (2001): 1S-2S. [PMID: 11157638]
87	Product Information. Abbokinase (urokinase). Abbott Pharmaceutical, Abbott Park, IL.
88	Product Information. Activase (alteplase). Genentech, South San Francisco, CA.
89	Product Information. Retavase (reteplase). Boehringer Mannheim, Gaithersburg, MD.
90	Product Information. Streptase (streptokinase). Astra USA, Westborough, MA.
91	Product Information. Ticlid (ticlopidine). Syntex Laboratories Inc, Palo Alto, CA.
92	Product Information. TNKase (tenecteplase) Genentech, South San Francisco, CA.
93	Caruso V, Iacoviello L, Di Castelnuovo A, et.al "Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients." Blood 108 (2006): 2216-22. [PMID: 16804111]
94	Duarte X, Esteves S, Neto AM, Pereira F "Incidence and risk factors for central nervous system thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre study." Br J Haematol 174 (2016): 280-91. [PMID: 27018199]
95	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
96	Product Information. Xiaflex (collagenase clostridium histolyticum). Auxilium Pharmaceuticals Inc, Norristown, PA.
97	Alderman CP, Moritz CK, Ben-Tovim DI "Abnormal platelet aggregation associated with fluoxetine therapy." Ann Pharmacother 26 (1992): 1517-9. [PMID: 1482806]
98	Alderman CP, Seshadri P, Ben-Tovim DI "Effects of serotonin reuptake inhibitors on hemostasis." Ann Pharmacother 30 (1996): 1232-4. [PMID: 8913401]
99	Aranth J, Lindberg C "Bleeding, a side effect of fluoxetine." Am J Psychiatry 149 (1992): 412. [PMID: 1536285]
100	Bannister SJ, Houser VP, Hulse JD, Kisicki JC, Rasmussen JG "Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin." Acta Psychiatr Scand Suppl 350 (1989): 102-6. [PMID: 2530759]
101	Ciraulo DA, Shader RI "Fluoxetine drug-drug interactions. II." J Clin Psychopharmacol 10 (1990): 213-7. [PMID: 2198298]
102	Claire RJ, Servis ME, Cram DL Jr "Potential interaction between warfarin sodium and fluoxetine." Am J Psychiatry 148 (1991): 1604. [PMID: 1928485]
103	Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH "Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study." Arch Intern Med 163 (2003): 59-64. [PMID: 12523917]
104	de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S "Intracranial haemorrhage and use of selective serotonin reuptake inhibitors." Br J Clin Pharmacol 50 (2000): 43-7. [PMID: 10886117]
105	de Abajo FJ, Rodriguez LA, Montero D "Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study." BMJ 319 (1999): 1106-9. [PMID: 10531103]
106	de Maistre E, Allart C, Lecompte T, Bollaert PE "Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors." Am J Med 113 (2002): 530-2. [PMID: 12427509]
107	Dent LA, Orrock MW "Warfarin-fluoxetine and diazepam-fluoxetine interaction." Pharmacotherapy 17 (1997): 170-2. [PMID: 9017779]
108	Ford MA, Anderson ML, Rindone JP, Jaskar DW "Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin." J Clin Psychopharmacol 17 (1997): 110-2. [PMID: 10950474]
109	Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B "Paroxetine decreases platelet serotonin storage and platelet function in human beings." Clin Pharmacol Ther 68 (2000): 435-42. [PMID: 11061584]
110	Humphries JE, Wheby MS, VandenBerg SR "Fluoxetine and the bleeding time." Arch Pathol Lab Med 114 (1990): 727-8. [PMID: 2363631]
111	Krivy J, Wiener J "Sertraline and platelet counts in idiopathic thrombocytopenia purpura." Lancet 345 (1995): 132. [PMID: 7815874]
112	Leung M, Shore R "Fluvoxamine-associated bleeding." Can J Psychiatry 41 (1996): 604-5. [PMID: 8946088]
113	Messiha FS "Fluoxetine - adverse effects and drug-drug interactions." J Toxicol Clin Toxicol 31 (1993): 603-30. [PMID: 8254702]
114	Ottervanger JP, Stricker BH, Huls J, Weeda JN "Bleeding attributed to the intake of paroxetine." Am J Psychiatry 151 (1994): 781-2. [PMID: 8166328]
115	Pai VB, Kelly MW "Bruising associated with the use of fluoxetine." Ann Pharmacother 30 (1996): 786-8. [PMID: 8826562]
116	Product Information. Brintellix (vortioxetine). Takeda Pharmaceuticals America, Lincolnshire, IL.
117	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
118	Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
119	Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
120	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
121	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
122	Product Information. Paxil (paroxetine). GlaxoSmithKline, Research Triangle Park, NC.
123	Product Information. Pristiq (desvenlafaxine). Wyeth Laboratories, Philadelphia, PA.
124	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
125	Product Information. Savella (milnacipran). Forest Pharmaceuticals, St. Louis, MO.
126	Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
127	Product Information. Zoloft (sertraline). Roerig Division, New York, NY.
128	Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30. [PMID: 9796863]
129	Skop BP, Brown TM "Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors." Psychosomatics 37 (1996): 12-6. [PMID: 8600488]
130	Woolfrey S, Gammack NS, Dewar MS, Brown PJ "Fluoxetine-warfarin interaction." BMJ 307 (1993): 241. [PMID: 8369688]
131	Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ "Fluoxetine and bleeding in obsessive-compulsive disorder." Am J Psychiatry 148 (1991): 949. [PMID: 2053641]
132	Layton D, Clark DWJ, Pearce GL, Shakir SAW "Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England." Eur J Clin Pharmacol 57 (2001): 167-76. [PMID: 11417450]
133	Tata LJ, Fortun PJ, Hubbard RB, et al. "Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?" Aliment Pharmacol Ther 22 (2005): 175-81. [PMID: 16091054]
134	Li XL, Steiner M "Fish oil: a potent inhibitor of platelet adhesiveness." Blood 76 (1990): 938-45. [PMID: 2118400]
135	Product Information. Vascepa (icosapent). Amarin Pharmaceuticals Inc, Warren, NJ.
136	Elice F, Rodeghiero F "Hematologic malignancies and thrombosis." Thromb Res 129 (2012): 360-6. [PMID: 22197450]
137	Grace RF, DeAngelo DJ, Stevenson KE, et.al "The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia." J Thromb Thrombolysis 45 (2018): 306-14. [PMID: 29260426]
138	Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Bohles H "Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia." J Pediatr Hematol Oncol 25 (2003): 484-7. [PMID: 12794528]
139	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
140	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
141	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
142	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
143	Truelove E, Fielding AK, Hunt BJ "The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia." Leukemia 27 (2013): 553-9. [PMID: 23099335]
144	Mitchell L, Andrew M, Hanna K, et.al "Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study." Thromb Haemost 90 (2003): 235-44. [PMID: 12888870]
145	Ranhosky A, Kempthorne-Rawson J, the Intravenous Dipyridamole Thallium Imaging Study Group "The safety of intravenous dipyridamole thallium myocardial perfusion imaging." Circulation 81 (1990): 1205-9. [PMID: 2107985]
146	Product Information. Lotronex (alosetron). Glaxo Wellcome, Research Triangle Park, NC.
147	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
148	Gidal BE, Sorkness CA, McGill KA, Larson R, Levine RR "Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patients." Ther Drug Monit 17 (1995): 33-8. [PMID: 7725374]
149	Product Information. Coumadin (warfarin). DuPont Pharmaceuticals, Wilmington, DE.
150	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
151	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
152	Belle DJ, Ernest CS, Sauer JM, Smith BP, Thomasson HR, Witcher JW "Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics." J Clin Pharmacol 42 (2002): 1219-27. [PMID: 12412820]
153	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
154	Product Information. Strattera (atomoxetine). Lilly, Eli and Company, Indianapolis, IN.
155	Product Information. Treanda (bendamustine). Cephalon Inc, West Chester, PA.
156	Product Information. Acular (ketorolac). Allergan Inc, Irvine, CA.
157	Product Information. Nevanac (nepafenac ophthalmic). Alcon Laboratories Inc, Fort Worth, TX.
158	Product Information. Xibrom (bromfenac ophthalmic). ISTA Pharmaceuticals, Irvine, CA.
159	Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
160	Product Information. Contrave (buPROPion-naltrexone). Orexigen Therapeutics Inc, La Jolla, CA.
161	Product Information. Forfivo XL (buPROPion (bupropion)). Almatica Pharma Inc, Parsippany, NJ.
162	Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
163	Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
164	Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
165	Richter T, Muerdter TE, Heinkele G, et al. "Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine." J Pharmacol Exp Ther 308 (2004): 189-97. [PMID: 14563790]
166	Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O "Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro." Drug Metab Dispos 32 (2004): 626-31. [PMID: 15155554]
167	Turpeinen M, Tolonen A, Uusitalo J, Jalonen J, Pelkonen O, Laine K "Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation." Clin Pharmacol Ther 77 (2005): 553-9. [PMID: 15961986]
168	Product Information. Celebrex (celecoxib). Searle, Chicago, IL.
169	Product Information. Onfi (clobazam). Lundbeck Inc, Deerfield, IL.
170	Caraco Y, Sheller J, Wood AJJ "Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects." J Pharmacol Exp Ther 290 (1999): 413-22. [PMID: 10381807]
171	Caraco Y, Sheller J, Wood JJ "Pharmacogenetic determination of the effects of codeine and prediction of drug interactions." J Pharmacol Exp Ther 278 (1996): 1165-74. [PMID: 8819499]
172	Desmeules J, Dayer P, Gascon MP, Magistris M "Impact of genetic and environmental factors on codeine analgesia." Clin Pharmacol Ther 45 (1989): 122. [PMID: 1782973]
173	Desmeules J, Gascon MP, Dayer P, Magistris M "Impact of environmental and genetic factors on codeine analgesia." Eur J Clin Pharmacol 41 (1991): 23-6. [PMID: 1782973]
174	Hersh EV, Moore PA "Drug interactions in dentistry: the importance of knowing your CYPs." J Am Dent Assoc 135 (2004): 298-311. [PMID: 15058617]
175	Poulsen L, Brosen K, Srendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH "Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects." Eur J Clin Pharmacol 51 (1996): 289-95. [PMID: 9010701]
176	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
177	Sindrup SH, Arendt-Nielsen L, Brosen K, et al "The effect of quinidine on the analgesic effect of codeine." Eur J Clin Pharmacol 42 (1992): 587-92. [PMID: 1623898]
178	Sindrup SH, Brosen K, Bjerring P, et al. "Codeine increases pain threshold to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine." Clin Pharmacol Ther 49 (1991): 686-93. [PMID: 2249379]
179	Sindrup SH, Hofmann U, Asmussen J, Mikus G, Brosen K, Nielsen F, Ingwersen SH, Broen Christensen C "Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake." Eur J Clin Pharmacol 49 (1996): 503-9. [PMID: 8706777]
180	Thorn CF, Klein TE, Altman RB "Codeine and morphine pathway." Pharmacogenet Genomics 19 (2009): 556-8. [PMID: 19512957]
181	Vevelstad M, Pettersen S, Tallaksen C, Brors O "O-demethylation of codeine to morphine inhibited by low-dose levomepromazine." Eur J Clin Pharmacol 65 (2009): 795-801. [PMID: 19308365]
182	Zhou SF "Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II." Clin Pharmacokinet 48 (2009): 761-804. [PMID: 19902987]
183	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
184	Product Information. Kybella (deoxycholic acid). Kythera Biopharmaceuticals, Inc., Westlake Village, CA.
185	Funck-Brentano C, Jacqz-Aigrain E, Leenhardt A, Roux A, Poirier JM, Jaillon P "Influence of amiodarone on genetically determined drug metabolism in humans." Clin Pharmacol Ther 50 (1991): 259-66. [PMID: 1914360]
186	Product Information. Zytiga (abiraterone). Centocor Inc, Malvern, PA.
187	Product Information. Viberzi (eluxadoline). Actavis Pharma, Inc., Parsippany, NJ.
188	Product Information. Flolan (epoprostenol). Glaxo Wellcome, Research Triangle Park, NC.
189	Product Information. Remodulin (treprostinil). United Therapeutics Corp, Silver Spring, MD.
190	Product Information. Ventavis (iloprost). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
191	Canadian Pharmacists Association.
192	Chan BSH, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG "Serotonin syndrome resulting from drug interactions." Med J Aust 169 (1998): 523-5. [PMID: 9861909]
193	Corkeron MA "Serotonin syndrome - a potentially fatal complication of antidepressant therapy." Med J Aust 163 (1995): 481-2. [PMID: 7476638]
194	Insel TR, Roy BF, Cohen RM, Murphy DL "Possible development of the serotonin syndrome in man." Am J Psychiatry 139 (1982): 954-5. [PMID: 7091416]
195	Laird LK "Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder." Psychopharmacol Bull 32 (1996): 569-78. [PMID: 8993077]
196	Lane R, Baldwin D "Selective serotonin reuptake inhibitor--induced serotonin syndrome: review." J Clin Psychopharmacol 17 (1997): 208-21. [PMID: 9169967]
197	Martin TG "Serotonin syndrome." Ann Emerg Med 28 (1996): 520-6. [PMID: 8909274]
198	Mills KC "Serotonin syndrome: A clinical update." Crit Care Clin 13 (1997): 763. [PMID: 9330840]
199	Nierenberg DW, Semprebon M "The central nervous system serotonin syndrome." Clin Pharmacol Ther 53 (1993): 84-8. [PMID: 8257462]
200	Nijhawan PK, Katz G, Winter S "Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission." Crit Care Med 24 (1996): 1086-9. [PMID: 8681579]
201	Sternbach H "The serotonin syndrome." Am J Psychiatry 148 (1991): 705-13. [PMID: 2035713]
202	Ha-Duong NT, Dijols S, Macherey AC, Goldstein JA, Dansette PM, Mansuy D "Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19." Biochemistry 40 (2001): 12112-22. [PMID: 11580286]
203	Klaassen SL "Ticlopidine-induced phenytoin toxicity." Ann Pharmacother 32 (1998): 1295-8. [PMID: 9876809]
204	Riva R, Cerullo A, Albani F, Baruzzi A "Ticlopidine impairs phenytoin clearance: a case report." Neurology 46 (1996): 1172-3. [PMID: 8780118]
205	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
206	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
207	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
208	Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
209	Donahue S, Flockhart DA, Abernethy DR "Ticlopidine inhibits phenytoin clearance." Clin Pharmacol Ther 66 (1999): 563-8. [PMID: 10613611]
210	Donahue SR, Flockhart DA, Abernathy DR, Jae-Wook Ko "Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19." Clin Pharmacol Ther 62 (1997): 572-7. [PMID: 9390115]
211	Giancarlo GM, Venkatakrishnan K, Granda BW, vonMoltke LL, Greenblatt DJ "Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine." Eur J Clin Pharmacol 57 (2001): 31-6. [PMID: 11372587]
212	Ko JW, Desta Z, Soukhova NV, Tracy T, Flockhart DA "In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6." Br J Clin Pharmacol 49 (2000): 343-51. [PMID: 10759690]
213	Privitera M, Welty TE "Acute phenytoin toxicity followed by seizure breakthrough from a ticlopidine-phenytoin interaction." Arch Neurol 53 (1996): 1191-2. [PMID: 8912496]
214	Rindone JP, Bryan G "Phenytoin toxicity associated with ticlopidine administration." Arch Intern Med 156 (1996): 1113. [PMID: 8639000]
215	Burnham BE "Garlic as a possible risk for postoperative bleeding." Plast Reconstr Surg 95 (1995): 213. [PMID: 7809259]
216	Chutani SK, Bordia A "The effect of fried versus raw garlic on fibrinolytic activity in man." Atherosclerosis 38 (1981): 417-21. [PMID: 7225179]
217	Evans V "Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use." J Neurosci Nurs 32 (2000): 229-32. [PMID: 10994537]
218	Fugh-Berman A "Herb-drug interactions." Lancet 355 (2000): 134-8. [PMID: 10675182]
219	German K, Kumar U, Blackford HN "Garlic and the risk of TURP bleeding." Br J Urol 76 (1996): 518. [PMID: 7551902]
220	Heck AM, DeWitt BA, Lukes AL "Potential interactions between alternative therapies and warfarin." Am J Health Syst Pharm 57 (2000): 1221-7 quiz 1228-30. [PMID: 10902065]
221	Izzo AA, Ernst E "Interactions between herbal medicines and prescribed drugs: a systematic review." Drugs 61 (2001): 2163-75. [PMID: 11772128]
222	Kiesewetter H, Jung F, Jung EM, Mrowietz C, Kosciehlny J, Wenzel E "Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack." Eur J Clin Pharmacol 45 (1993): 333-6. [PMID: 8299665]
223	Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S "Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects." Arzneimittelforschung 43 (1993): 119-22. [PMID: 8457236]
224	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
225	Morris J, Burke V, Mori TA, Vandongen R, Beilin LJ "Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study." Clin Exp Pharmacol Physiol 22 (1995): 414-7. [PMID: 8582091]
226	Steiner M, Lin RS "Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract." J Cardiovasc Pharmacol 31 (1998): 904-8. [PMID: 9641475]
227	Vaes LP, Chyka PA "Interactions of warfarin with garlic, ginger, or ginseng: nature of evidence." Ann Pharmacother 34 (2000): 1478-82. [PMID: 11144706]
228	Apitz-Castro R, Escalante J, Vargas R, Jain MK "Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets." Thromb Res 42 (1986): 303-11. [PMID: 3520940]
229	Mulrow C, Lawrence V, Ackermann R, et al. Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects.?Evid Rep Technol Assess (Summ). 2000;(20):1-4. [PMID: 11089496]
230	Benjamin J, Muir T, Briggs K, Pentland B "A case of cerebral haemorrhage - can Ginkgo biloba be implicated?." Postgrad Med J 77 (2001): 112-3. [PMID: 11161079]
231	Chung KF, McCusker M, Page CP, Dent G, Guinot P, Barnes PJ "Effect of ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet acitivating factor in man." Lancet 1 (1987): 248-51. [PMID: 2880069]
232	Cupp MJ "Herbal remedies: adverse effects and drug interactions." Am Fam Physician 59 (1999): 1239-45. [PMID: 10088878]
233	Engelsen J, Nielsen JD, Winther K "Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial." Thromb Haemost 87 (2002): 1075-6. [PMID: 12083489]
234	Fessenden JM, Wittenborn W, Clarke L "Gingko biloba: A case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy." Am Surg 67 (2001): 33-5. [PMID: 11206893]
235	Fong KC, Kinnear PE "Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion." Postgrad Med J 79 (2003): 531-2. [PMID: 13679551]
236	Jayasekera N, Moghal A, Kashif F, Karalliedde L "Herbal medicines and postoperative haemorrhage." Anaesthesia 60 (2005): 725-6. [PMID: 15960738]
237	Jiang X, Williams KM, Liauw WS, et al. "Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects." Br J Clin Pharmacol 59 (2005): 425-32. [PMID: 15801937]
238	Matthews MK Jr "Association of Ginko biloba with intracerebral hemorrhage." Neurology 50 (1998): 1933-4. [PMID: 9633781]
239	Rosenblatt M, Mindel J "Spontaneous hyphema associated with ingestion of Ginkgo biloba extract." N Engl J Med 336 (1997): 1108. [PMID: 9091822]
240	Rowin J, Lewis SL "Spontaneous bilateral subdural hematomas associated with chronic Gingko biloba ingestion." Neurology 46 (1996): 1775-6. [PMID: 8649594]
241	Sierpina VS, Wollschlaeger B, Blumenthal M "Ginkgo biloba." Am Fam Physician 68 (2003): 923-6. [PMID: 13678141]
242	Wolf HR "Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?" Drugs R D 7 (2006): 163-72. [PMID: 16752942]
243	Ang-Lee MK, Moss J, Yuan CS "Herbal medicines and perioperative care." JAMA 286 (2001): 208-16. [PMID: 11448284]
244	Heck AM, DeWitt BA, Lukes AL "Potential interactions between alternative therapies and warfarin." Am J Health Syst Pharm 57 (2000): 1221-7 quiz 1228-30. [PMID: 10902065]
245	Hodges PJ, Kam PC "The peri-operative implications of herbal medicines." Anaesthesia 57 (2002): 889-99. [PMID: 12190754]
246	Product Information. Panhematin (hemin). Recordati Rare Diseases Inc, Lebanon, NJ.
247	Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
248	Product Information. Ofev (nintedanib). Boehringer Ingelheim, Ridgefield, CT.
249	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
250	Product Information. Elmiron (pentosan polysulfate sodium). Baker Norton Pharmaceuticals, Miami, FL.
251	Product Information. Trental (pentoxifylline). Hoechst Marion-Roussel Inc, Kansas City, MO.
252	Krahenbuhl S, Sauter B, Kupferschmidt H, Krause M, Wyss PA, Meier PJ "Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication." Am J Med Sci 309 (1995): 315-6. [PMID: 7771501]
253	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
254	Product Information. Esbriet (pirfenidone). Intermune Inc, Brisbane, CA.
255	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
256	Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
257	Product Information. Daliresp (roflumilast). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
258	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
259	Product Information. Noroxin (norfloxacin). Merck & Co, Inc, West Point, PA.
260	Product Information. Requip (ropinirole). SmithKline Beecham, Philadelphia, PA.
261	Booth SL, Golly I, Sacheck JM, Roubenoff R, Dallal GE, et al "Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status." Am J Clin Nutr 80 (2004): 143-8. [PMID: 15213041]
262	Murohara T, Ikeda H, Otsuka Y, Aoki M, Takajo Y, et al "Inhibition of platelet adherence to Mononuclear cells by alpha-tocopherol: role of P-selection." Circulation 110 (2004): 141-8. [PMID: 15197142]
263	Vitamin K, vitamin E and the coumarin drugs. Nutr Rev 40 (1982): 180-2. [PMID: 7121898]
264	Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
265	Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
266	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
267	Edeki TI, He HB, Wood AJJ "Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops: potential for oral-ophthalmic drug interaction." JAMA 274 (1995): 1611-3. [PMID: 7474246]
268	Fraunfelder FT, Fraunfelder FW Randall JA "Drug-Induced Ocular Side Effects 5th" Boston, MA: Butterworth-Heinemann (2001):.
269	Lewis RV, Lennard MS, Jackson PR, Tucker GT, Ramsay LE, Woods HF "Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics." Br J Clin Pharmacol 19 (1985): 329-33. [PMID: 2859048]
270	Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
271	Product Information. Xatral (alfuzosin). Sanofi-Synthelabo Canada Inc, Markham, ON.
272	Celestini A, Pulcinelli FM, Pignatelli P, et al. "Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets." Haematologica 87 (2002): 420-6. [PMID: 11940487]
273	Corrigan JJ "The effect of vitamin E on warfarin-induced vitamin K deficiency." Ann N Y Acad Sci 393 (1982): 361-8. [PMID: 6959563]
274	Corrigan JJ, Ulfers LL "Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency." Am J Clin Nutr 34 (1981): 1701-5. [PMID: 7282596]
275	Freedman JE, Farhat JH, Loscalzo J, Keaney JF "Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C--dependent mechanism." Circulation 94 (1996): 2434-40. [PMID: 8921785]
276	Gonzalez-Correa JA, Arrebola MM, Guerrero A, et al. "Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood." Platelets 16(3-4) (2005): 171-9. [PMID: 16011961]
277	Helson L "The effect of intravenous vitamin E and menadiol sodium diphosphate on vitamin K dependent clotting factors." Thromb Res 35 (1984): 11-8. [PMID: 6474408]
278	Jandak J, Steiner M, Richardson PD "Alpha-tocopherol, an effective inhibitor of platelet adhesion." Blood 73 (1989): 141-9. [PMID: 2910355]
279	Kakishita E, Suehiro A, Oura Y, Nagai K "Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood." Thromb Res 60 (1990): 489-99. [PMID: 2082481]
280	Kim JM, White RH "Effect of vitamin E on the anticoagulant response to warfarin." Am J Cardiol 77 (1996): 545-6. [PMID: 8629604]
281	Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T "Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms." Am J Clin Nutr 77 (2003): 700-6. [PMID: 12600864]
282	Mardla V, Kobzar G, Samel N "Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin." Platelets 15 (2004): 319-24. [PMID: 15370103]
283	Megavitamin E supplementation and vitamin K-dependent carboxylation. Nutr Rev 41 (1983): 268-70. [PMID: 6358960]
284	Schrogie JJ "Coagulopathy and fat-soluble vitamins." JAMA 232 (1975): 19. [PMID: 1172961]
285	Stampfer MJ, Jakubowski JA, Faigel D, Vaillancourt R, Deykin D "Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels." Am J Clin Nutr 47 (1988): 700-6. [PMID: 3128100]
286	Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C "Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis." Pharmacotherapy 27 (2007): 1237-47. [PMID: 17723077]
287	Product Information. Briviact (brivaracetam). UCB Pharma Inc, Smyrna, GA.
288	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
289	Lambert JP, Cormier J "Potential interaction between warfarin and boldo-fenugreek." Pharmacotherapy 21 (2001): 509-12. [PMID: 11310527]
290	Saeed SA, Gilani AH "Antithrombotic activity of clove oil." J Pak Med Assoc 44 (1994): 112-5. [PMID: 8078176]
291	Srivasta KC "Antiplatelet principles from a food spice clove (Syzygium aromaticum L) [corrected]" Prostaglandins Leukot Essent Fatty Acids 48 (1993): 363-72. [PMID: 8321872]
292	Srivstava KC, Malhotra N "Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets." Prostaglandins Leukot Essent Fatty Acids 42 (1991): 73-81. [PMID: 2011614]
293	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
294	Rojas-Fernandez C, Fisher C "Drug interactions and donepezil." J Am Geriat Soc 40 (2000): 597-8. [PMID: 10811561]
295	Tiseo PJ, Perdomo CA, Friedhoff LT "Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses." Br J Clin Pharmacol 46 (1998): 30-4. [PMID: 9839763]
296	Klotz U "The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications." Clin Pharmacokinet 46 (2007): 271-9. [PMID: 17375979]
297	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
298	Brynne N, Svanstrom C, AbergWistedt A, Hallen B, Bertilsson L "Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance." Br J Clin Pharmacol 48 (1999): 553-63. [PMID: 10583026]
299	Product Information. Detrol (tolterodine). Pharmacia and Upjohn, Kalamazoo, MI.
300	Abebe W "Herbal medication: potential for adverse interactions with analgesic drugs." J Clin Pharm Ther 27 (2002): 391-401. [PMID: 12472978]
301	Yang X, Thomas DP, Zhang X, et al "Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation." Arterioscler Thromb Vasc Biol 26 (2006): 85-90. [PMID: 16239599]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence